BioLife Solutions, Inc.

NasdaqCM:BLFS Lagerbericht

Marktkapitalisierung: US$1.2b

BioLife Solutions Management

Management Kriterienprüfungen 1/4

BioLife Solutions CEO ist Rod de Greef , ernannt in Oct 2023, hat eine Amtszeit von 1.08 Jahren. Die jährliche Gesamtvergütung beträgt $6.39M , bestehend aus 3.1% Gehalt und 96.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.14% der Aktien des Unternehmens, im Wert von $1.68M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.1 Jahre bzw. 16 Jahre.

Wichtige Informationen

Rod de Greef

Geschäftsführender

US$6.4m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts3.1%
Amtszeit als Geschäftsführer1.1yrs
Eigentum des Geschäftsführers0.1%
Durchschnittliche Amtszeit des Managements1.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder16yrs

Jüngste Management Updates

Recent updates

Analysts Have Lowered Expectations For BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results

Nov 15
Analysts Have Lowered Expectations For BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results

Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Oct 25
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Sep 14
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Why BioLife Solutions, Inc. (NASDAQ:BLFS) Could Be Worth Watching

Aug 30
Why BioLife Solutions, Inc. (NASDAQ:BLFS) Could Be Worth Watching

Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

Aug 14
Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Jun 20
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Jun 05
A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

May 14
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

May 13
Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

May 11
Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

Mar 12
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

Feb 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Dec 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Aug 17
Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Aug 11
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

May 06
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Feb 22
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Jan 10
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Dec 10
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

BioLife: What The Future Holds

Oct 19

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rod de Greef im Vergleich zu den Einnahmen von BioLife Solutions verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$49m

Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$62m

Dec 31 2023US$6mUS$199k

-US$66m

Sep 30 2023n/an/a

-US$79m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$141m

Dec 31 2022US$2mUS$450k

-US$140m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$96m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$1mUS$412k

-US$9m

Sep 30 2021n/an/a

US$5m

Jun 30 2021n/an/a

US$4m

Mar 31 2021n/an/a

-US$20m

Dec 31 2020US$3mUS$391k

US$2m

Sep 30 2020n/an/a

US$7m

Jun 30 2020n/an/a

US$16m

Mar 31 2020n/an/a

US$39m

Dec 31 2019US$1mUS$403k

-US$2m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$490kUS$350k

-US$25m

Sep 30 2018n/an/a

US$1m

Jun 30 2018n/an/a

-US$146k

Mar 31 2018n/an/a

-US$2m

Dec 31 2017US$520kUS$300k

-US$3m

Vergütung im Vergleich zum Markt: RodDie Gesamtvergütung ($USD6.39M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD3.20M).

Entschädigung vs. Einkommen: RodDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Rod de Greef (64 yo)

1.1yrs

Amtszeit

US$6,387,586

Vergütung

Mr. Roderick de Greef, also known as Rod, serves as Director of BioLife Solutions, Inc. since January 03, 2023 and serves as its Chief Executive Officer & Chairman since October 20, 2023. He had been Presi...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Roderick de Greef
CEO & Chairman1.1yrsUS$6.39m0.14%
$ 1.7m
Troy Wichterman
Chief Financial Officer3yrsUS$1.70m0.27%
$ 3.1m
Karen Foster
Chief Quality & Operations Officerless than a yearUS$1.12m0.34%
$ 3.9m
Aby Mathew
Chairman of Scientific Advisory Board4.9yrsUS$1.35m0.68%
$ 7.9m
Sean Werner
Chief Technology Officerno datakeine Datenkeine Daten
Todd Berard
Chief Commercial Officerno dataUS$734.45k0.23%
$ 2.7m
Sarah Aebersold
Chief Human Resources Officer3.8yrskeine Daten0.13%
$ 1.5m

1.1yrs

Durchschnittliche Betriebszugehörigkeit

53.5yo

Durchschnittliches Alter

Erfahrenes Management: BLFSDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.1 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Roderick de Greef
CEO & Chairman1.8yrsUS$6.39m0.14%
$ 1.7m
Aby Mathew
Chairman of Scientific Advisory Boardno dataUS$1.35m0.68%
$ 7.9m
Shelly Heimfeld
Member of Scientific Advisory Board18.1yrskeine Datenkeine Daten
Scott Burger
Member of Scientific Advisory Board17.2yrskeine Datenkeine Daten
Dayong Gao
Member of Scientific Advisory Board18.1yrskeine Datenkeine Daten
Andrew Hinson
Member of the Scientific Advisory Boardno dataUS$284.00kkeine Daten
Erik Woods
Member of Scientific Advisory Board17.2yrskeine Datenkeine Daten
Lizabeth Cardwell
Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
Amy DuRoss
Independent Lead Director3.6yrsUS$269.17k0.039%
$ 454.7k
Joydeep Goswami
Independent Director3.1yrsUS$250.00k0.064%
$ 746.4k
Colleen Delaney
Member of Scientific Advisory Board16yrskeine Datenkeine Daten
John McMannis
Member of Scientific Advisory Board12.8yrskeine Datenkeine Daten

16.0yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: BLFSDie Vorstandsmitglieder sind sehr erfahren ( 16 ).